Pacer S&P 500 Quality FCF R&D Leaders
 
 
 
 
基本資料
種類: ETF
費用比率%: --
資產淨值: 24.04
成立日期: //
 
分析
市值分佈:
95.20%
大市值
--
中市值
--
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 07/03/2026 05:58) 總持有投資項目: 47  
0%
 
100%
     10大 (33.56%)
代號 名稱 佔比% 持有日期
MRKMerck & Co3.9327/02/2026
VRTXVertex Pharmaceuticals3.8127/02/2026
INCYIncyte Corp3.7427/02/2026
REGNRegeneron Pharmaceuticals3.5727/02/2026
TERTeradyne3.1927/02/2026
BIIBBiogen3.1427/02/2026
EAElectronic Arts3.1227/02/2026
KEYSKeysight Technologies3.0627/02/2026
SNPSSynopsys3.0027/02/2026
CDNSCadence Design Systems3.0027/02/2026
BMYBristol-Myers Squibb Co2.9227/02/2026
ABNBAirbnb2.8927/02/2026
DDOGDatadog2.3727/02/2026
GILDGilead Sciences2.2927/02/2026
AMGNAmgen2.1727/02/2026
METAMeta Platforms2.1527/02/2026
ADIAnalog Devices2.1427/02/2026
JNJJohnson & Johnson2.0127/02/2026
EWEdwards Lifesciences Corp1.9527/02/2026
CRWDCrowdStrike Holdings1.9327/02/2026
 1    2    3  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.